MEDICAMEN ORGANICS — Quarterly Results & Earnings

₹21.10

+2.42%

Profit Growth YoY35.10%Latest quarter

Sales Growth YoY7.47%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+35.10%

🔥 Exceptional growth

YoY Sales Growth+7.47%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

10.65

ROE

17.85%

ROCE

16.88%

💡

Growth Analysis

MEDICAMEN ORGANICS reported YoY profit growth of 35.10% and revenue growth of 7.47% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on MEDICAMEN ORGANICS

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.